| C2RS34 Stock | | | 31.52 0.00 0.00% |
CRISPR Therapeutics technical analysis lookup allows you to check this and other technical indicators for CRISPR Therapeutics AG or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also
Equity Screeners to view more equity screening tools
CRISPR Therapeutics AG has current Coefficient Of Variation of 13518.77. Coefficient of Variation (or CV) is a normalized measure of dispersion of a probability distribution. It is also known as the variation coefficient or simply unitized risk. The absolute value of the Coefficient of Variation is sometimes called Relative Standard Deviation (or RSD), which is expressed as a percentage.
Coefficient Of Variation | = | STDER |
| = | 13518.77 | |
CRISPR Therapeutics Coefficient Of Variation Peers Comparison
CRISPR Coefficient Of Variation Relative To Other Indicators
CRISPR Therapeutics AG is number one stock in coefficient of variation category among its peers. It is currently under evaluation in jensen alpha category among its peers . The ratio of Coefficient Of Variation to Jensen Alpha for CRISPR Therapeutics AG is about
1,553,881 CV is the measure of price and return dispersion, sometimes known as unitized risk or the variation coefficient. The CV is derived from the ratio of the standard deviation to the non-zero mean and the absolute value is taken for the mean to ensure it always positive. It is sometimes expressed as a percentage, in which case the CV is multiplied by 100. Coefficient of Variation for a single equity instrument describes the dispersion of price movement or daily returns. The higher the Coefficient of Variation, the greater the dispersion of prices, and the more riskier is the asset.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.